https://www.alphaview.kr 실시간 미국 주식 뉴스를 AI로 분석하여 시장 정보를 제공합니다. ko Mon, 26 Oct 2026 13:44:40 GMT https://www.alphaview.kr/images/brand/logo.png https://www.alphaview.kr Copyright 2026 AlphaView. All rights reserved. contact@alphaview.kr (AlphaView) contact@alphaview.kr (AlphaView) 30 https://www.alphaview.kr/news/34769-칸델-전립선암-3상-연장-추적서-can-2409-장기-임상-이점-보고 Fri, 15 May 2026 20:05:00 GMT https://www.alphaview.kr/news/34769-칸델-전립선암-3상-연장-추적서-can-2409-장기-임상-이점-보고 바이오/헬스케어 globenewswire GlobeNewswire https://www.alphaview.kr/news/35282-candel-therapeutics-2026년-1분기-재무-결과-및-최근-기업-하이라이트-발표 Thu, 14 May 2026 12:05:00 GMT https://www.alphaview.kr/news/35282-candel-therapeutics-2026년-1분기-재무-결과-및-최근-기업-하이라이트-발표 바이오/헬스케어 globenewswire GlobeNewswire https://www.alphaview.kr/news/35675-candel-therapeutics-다가오는-투자자-컨퍼런스에서-발표-예정 Wed, 13 May 2026 12:05:00 GMT https://www.alphaview.kr/news/35675-candel-therapeutics-다가오는-투자자-컨퍼런스에서-발표-예정 바이오/헬스케어 globenewswire GlobeNewswire https://www.alphaview.kr/news/32614-candel-therapeutics-국소-전립선암-치료제-aglatimagene-besadenovec의-잠재적-미국-출시-지원을-위해-evers Wed, 29 Apr 2026 12:06:46 GMT https://www.alphaview.kr/news/32614-candel-therapeutics-국소-전립선암-치료제-aglatimagene-besadenovec의-잠재적-미국-출시-지원을-위해-evers 바이오/헬스케어 globenewswire GlobeNewswire https://www.alphaview.kr/news/16713-candel-therapeutics-미국-비뇨기과-학회에서-국소-전립선암-치료제-aglatimagene-besadenovec의-장기-추적-연구 Mon, 09 Mar 2026 12:06:42 GMT https://www.alphaview.kr/news/16713-candel-therapeutics-미국-비뇨기과-학회에서-국소-전립선암-치료제-aglatimagene-besadenovec의-장기-추적-연구 바이오/헬스케어 globenewswire GlobeNewswire https://www.alphaview.kr/news/9547-candel-therapeutics-공모-가격-발표 Fri, 20 Feb 2026 02:40:00 GMT https://www.alphaview.kr/news/9547-candel-therapeutics-공모-가격-발표 바이오/헬스케어 globenewswire GlobeNewswire